Document:

exv10w8

 

EXHIBIT 10.8

MANAGEMENT SERVICES AGREEMENT

     THIS MANAGEMENT SERVICES AGREEMENT (the “Agreement”) is entered into this 12th day of May,
2006, by and between VV III Management, LLC, a Delaware limited liability company (“Contractor”)
and OrthoLogic Corp., a Delaware corporation (the “Company”).

RECITALS

     WHEREAS, the Company wishes to engage Contractor to make available the services of John M.
Holliman, III (“Executive”) to serve as the Company’s Executive Chairman and principal executive
officer; and

     WHEREAS, Contractor wishes to make available the services of Executive to the Company on the
terms and conditions set forth in this Agreement.

     NOW, THEREFORE, the parties agree as follows:

AGREEMENT

     1. Services. Pursuant to the terms of this Agreement, Contractor shall cause
Executive to serve, and Executive shall serve as the Company’s Executive Chairman and principal
executive officer with responsibility for corporate strategy, executive management, investor
relations, financial reporting and compliance. Contractor shall cause Executive to (i) devote the
time, attention, skill and efforts to the performance of such duties as are normal and customary to
the position of principal executive officer and as reasonably requested by the Company’s Board of
Directors (the “Board”); and (ii) comply with any and all rules of conduct established by the
Company and to perform any and all assigned duties in a manner that is acceptable to the Company.

     2. Management Fee; Bonus; Reimbursement.

          (a) Compensation. Company shall pay Contractor a management fee at the rate of
$200,000 per year (the “Management Fee”) payable on the first and fifteenth day of each calendar
month, retroactive to April 5, 2006.

          (b) Bonuses. Executive shall be entitled to participate in a discretionary bonus plan
established for Executive from time to time by the Compensation Committee of the Board (the
“Compensation Committee”). The target bonus will be 40% of the annual Management Fee upon the
achievement by Executive of individual and corporate performance objectives established from time
to time by the Compensation Committee. Such cash bonus, if earned, will be payable to Contractor
annually on or before the first day of April immediately following the end of the calendar year for
which it is earned. Any bonus will be paid in such manner so that it is not subject to the
provisions of Section 409A of the Internal Revenue Code of 1986, as amended, and shall be
interpreted in a manner consistent with that intention.

 

 

          (c) Reimbursement. In addition to the Management Fee provided above, the Company
shall reimburse Executive, in accordance with the policies and practices of the Company in effect
from time to time with respect to other members of senior management of the Company, for all
reasonable and necessary traveling expenses and other disbursements incurred by him for or on
behalf of the Company in connection with the performance of his duties to the Company upon
presentation by Executive to the Company of appropriate documentation therefor.

          (d) Fringe Benefits. Except as otherwise provided in this Section 2, Executive will
not be entitled to participate in health, welfare, retirement or other similar benefit programs
made available from time to time to other executives and employees of the Company.

     3. Termination.

          (a) This Agreement may be terminated at any time by Contractor or the Company with or without
cause, notice or procedural formality. No individual or individuals associated with the Company,
other than the Compensation Committee acting pursuant to the powers granted to it by the Company,
has authority to make any agreement to the contrary, or any agreement for any specified period of
time. Any such agreement must be in writing and approved by the Compensation Committee to be
effective. The Company shall have no obligation to employ Executive after any such termination,
and upon any termination hereof, Contractor shall cause Executive to tender his resignation to the
Company.

          (b) Upon the termination of this Agreement, neither Contractor, Executive nor Executive’s
beneficiaries or estate shall have any further rights under this Agreement or any claims against
the Company arising out of this Agreement, except that Contractor shall be entitled to receive
accrued and unpaid Management Fees which are then due and owing as of the date of termination and,
in the event of a termination by the Company without cause in connection with or following a Change
of Control, as defined below, Contractor shall be entitled to a continuation of the semi-monthly
payment of the Management Fee for a period of six months from the date of termination. For
purposes of this Agreement, “cause” shall include Executive’s neglect of duties, willful failure to
abide by instructions or policies from or set by the Board, commission of a felony or serious
misdemeanor offense or pleading guilty or nolo contendere to same, Contractor’s breach of this
Agreement or Contractor’s or Executive’s breach of any other material obligation to the Company.

          (c) Upon the termination of this Agreement, Contractor shall, and shall cause Executive to
promptly deliver to the Company all equipment, documents and other company property in their
respective possession, custody or control.

          (d) As used herein, the term “Change of Control” shall be defined as a change in ownership or
control of the Company effected through any of the following transactions:

               (i) a statutory share exchange, merger, consolidation or reorganization approved by the
Company’s stockholders, unless securities representing more than 50% of the total combined voting
power of the voting securities of the successor corporation are immediately thereafter beneficially
owned, directly or indirectly, by the persons who beneficially owned the Company’s outstanding
voting securities immediately prior to such transaction;

2

 

               (ii) any stockholder approved transfer or other disposition of all or substantially all of the
Company’s assets (whether held directly or indirectly through one or more controlled subsidiaries)
except to or with a wholly-owned subsidiary of the Company); or

               (iii) the acquisition, directly or indirectly by any person or related group of persons of
beneficial ownership (within the meaning of Rule 13d-3 of the Securities Exchange Act of 1934, as
amended), of securities possessing more than 50% of the total combined voting power of the
Company’s outstanding securities pursuant to transactions with the Company’s stockholders and not
solely by direct purchase from the Company.

     4. Governing Law; Mediation. This Agreement is entered into in Arizona and shall in
all respects be interpreted, construed and governed by and in accordance with the laws of the State
of Arizona. The parties agree that any dispute between the parties relating to this Agreement
shall be subject to mediation according to the mediation rules of the American Arbitration
Association (the “AAA”) applicable to commercial disputes, such to be held at a mutually agreeable
office of the AAA in Phoenix, Arizona. Mediation shall be a condition precedent to litigation and
mediation shall in no way preclude either party from seeking and obtaining any prejudgment remedy
against the other party. By signing this Agreement, the parties submit themselves to the
jurisdiction of the courts of the State of Arizona, located in Maricopa County, for the purpose of
resolving any and all disputes arising out of this Agreement subject to the mediation procedures
set forth in this Section.

     5. Whole Agreement. This Agreement embodies all of the representations, warranties,
covenants and agreements between the parties and no other representations, warranties, covenants,
understandings or agreements exist, provided that it is understood that Executive shall enter into
an Indemnification Agreement and Intellectual Property, Confidentiality and Non-Competition
Agreement with the Company.

     6. Benefits of Agreement; Assignment. The terms and provisions of this Agreement
shall be binding upon and inure to the benefit of the parties hereto and their respective
successors, assigns, representatives, heirs and estate, as applicable. Anything contained herein
to the contrary notwithstanding, this Agreement shall not be assignable by any party hereto without
the consent of the other party hereto; provided, however, that the Company may assign this
Agreement in connection with a sale of all or substantially all of its assets or a merger.

     7. Amendment. This Agreement may not be amended orally but only by an instrument in
writing executed by the Company and Contractor.

SIGNATURE PAGE FOLLOWS

3

 

	 	 	 	 	 	 	 	 	 	 	 
	COMPANY:	 	 	 	CONTRACTOR:	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	ORTHOLOGIC CORP.	 	 	 	VV III MANAGEMENT, LLC	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	By:

	 	/s/ Fredric J. Feldman, Ph.D.
	 	 	 	By:
	 	/s/ John M. Holliman, III	 	 
	 

	 	 
	 	 	 	 	 	 	 	 
	Name:

	 	Fredric J. Feldman, Ph.D.
	 	 	 	Name:
	 	John M. Holliman, III	 	 
	Title:

	 	Chair Compensation Committee
	 	 	 	Title:
	 	Executive Chairman	 	 
	Date:

	 	May 12, 2006
	 	 	 	Date:
	 	May 12, 2006	 	 

ACKNOWLEDGEMENT

     Executive hereby acknowledges that he has read the foregoing Management Services Agreement and
acknowledges and agrees that Executive shall have no rights to employment or other benefits in
connection therewith, except as expressly provided therein. The Executive agrees that the
termination by either party of the Management Services Agreement shall constitute the tender by
Executive of his resignation from all positions held with the Company except, if applicable, as a
Director of the Company. The Executive further agrees that so long as Executive is serving as an
executive of the Company, Executive agrees that he shall: (i) devote the time, attention, skill
and efforts to the performance of such duties as are normal and customary for such position and as
reasonably requested by the Company’s Board of Directors; and (ii) use his best efforts to comply
with any and all rules of conduct established by the Company and to perform any and all assigned
duties in a manner that is acceptable to the Company.

EXECUTIVE:

	 	 	 	 	 
	Signature:

	 	/s/ John M. Holliman, III
	 	 
	 

	 	 	 	 
	 

	 	John M. Holliman, III	 	 
	 
	 	 	 	 
	Date: May 12, 2006	 	 

4Exhibit 10.1

    

    Director
      Compensation Policy

    for
      Non-Employee Directors of King Pharmaceuticals, Inc.

    

    As
      Approved by the Board of Directors on February 13, 2004

    and
      amended on July 22, 2005, February 22, 2006 and August 2,
      2006

    

    

    
      	 	 
	
              Retainer
                *

               

            	
              $38,000
                annually

            
	
              Board
                Meeting Fees

               

            	
              $2,000
                per meeting

            
	
              Committee
                Meeting Fees

               

            	
              $1,200
                per meeting

            
	
              Non-Executive
                Chairman of the Board Retainer

               

            	
              $120,000
                annually

            
	
              Audit
                Chair Retainer *

               

            	
              $10,000
                annually

            
	
              Other
                Chair Retainer *

               

            	
              $7,500
                annually

            
	
              Continuing
                Education Expenses

               

               

            	
              Reasonable
                and customary expenses

              (up
                to 3 days per year)

            
	
              Personal
                use of corporate aircraft

               

               

            	
              10
                hours of flight time

              per
                calendar year **

            
	
              Annual
                Grant of Restricted Stock Units

            	
              $120,000
                market value,

              restricted
                stock units ***

            

    

    

    

    Compensation
      to be received by each director pursuant to this policy may be deferred in
      accordance with the King Pharmaceuticals, Inc. Non-Employee Directors’ Deferred
      Compensation Plan. 

    

    
      	
              *

            	
              Fees
                are to be paid at the end of each quarter for service
                during that quarter. Fees for service during part of a quarter will
                be pro
                rated.

            

    

     

    
      	
              **

            	
              (1)
                10 hours are available to each director each calendar year. Unused
                hours
                do not accumulate from one year to the
                next.

            

    

     

    
      	 	
              (2)
                Each use pursuant to this provision shall require the prior authorization
                of the Chairman of the Board.

            

    

    
       

      
        	 	
                (3)
                  Use is limited to flights for which the primary purpose is King’s
                  business. The aircraft flight shall not be for purely personal
                  purposes.

              

      

      
         

        
          	 	
                  (4)
                    Flight time will accrue only while the director is on
                    board.

                

        

        
           

          
            	 	
                    (5)
                      Usage will be treated as compensation to the director as may
                      be required
                      by the Internal Revenue Code.

                  

          

           

        

      

    

    
      	 	
              (6)
                Reports of aircraft usage by non-employee directors will be provided
                not
                less than annually to the Compensation and Human Resources
                Committee.

            

    

     

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    
 

    ***
      Automatically awarded once annually through the King Pharmaceuticals, Inc.
      Incentive Plan.

    

    By
      resolution of the Board on February 13, 2004, as amended on February 22, 2006
      and August 2, 2006, restricted stock units related to King’s common stock,
      having a value of $120,000 at the time of grant (based upon the closing price
      of
      the common stock as of that date) are automatically granted to each non-employee
      director on April 30 of each year, or, if April 30 falls on a weekend or
      holiday, on the first business day immediately preceding April 30.

    

    Upon
      becoming a director (other than through re-election), the non-employee director
      shall automatically be granted, upon the first day of service as a director,
      such number of restricted stock units as have a value equal to the portion
      of
      $120,000 which is equivalent to the fraction of a year between the first date
      of
      service and the first April 30 thereafter.

    

    Restricted
      stock units granted pursuant to this provision have a restricted period which
      shall end on the date of the first to occur of the following events, and
      otherwise according to the terms of the Incentive Plan: (1) one year following
      the date of grant; (2) the director, standing for reelection, is not reelected;
      (3) the director completes his or her term of office after declining to stand
      for reelection; (4) the director completes his or her term of office after
      not being nominated to stand for reelection; (5) the director completes his
      or
      her term of office, having been ineligible to stand for reelection under term
      limit provisions then in effect.

    

    Notes
      to Schedule of Compensation for Non-Management Directors:

    

    The
      Board
      of Directors determined, on March 11, 2004, that the only compensation to be
      paid for participation in executive sessions of the non-management directors
      shall be a fee of $1,200 for attending an executive session of the
      non-management directors which is held on a day on which a Board meeting is
      not
      held. Retainers shall not otherwise be paid to the coordinating director or
      other participants for these activities.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00108-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00108-of-00352.parquet"}]]